Oura Health Eyes $16B IPO in 2026, Targets $3B Raise
By ThePip Desk
Oura Health, the smart ring maker, is preparing for a US IPO in September 2026, aiming for a $16B+ valuation and seeking to raise up to $3B.
Oura Health, maker of the sleep-tracking smart ring, is targeting a U.S. Initial Public Offering in September 2026. The company aims for a valuation exceeding $16 billion and seeks to raise up to $3 billion from the offering.
Key Financial Targets
- Target Valuation: over $16 billion
- Capital Sought: up to $3 billion
- 2026 Revenue Target: between $1.5 billion and $2 billion
- 2024 Reported Revenue: over $500 million
Oura Health confidentially filed for the IPO in May 2026. This move follows a strategic shift to expand beyond tech enthusiasts, now targeting a broader wellness market focused on sleep, stress management, and recovery.
IPO Challenges Ahead
The path to public markets includes significant hurdles. The wearable technology market is increasingly competitive, with rivals like Samsung introducing devices such as the Galaxy Ring.
Regulatory and legal issues also persist for Oura. The company has faced disputes regarding the accuracy of its health-monitoring data, with questions raised about its clinical-grade claims.
Underwriting Syndicate
The anticipated IPO will involve several prominent financial institutions. These firms are expected to manage the offering.
- Goldman Sachs
- Morgan Stanley
- JPMorgan Chase
- Allen & Co.
- Jefferies
The ultimate success of Oura’s IPO will depend on broader economic factors and investor interest in new technology stocks. The company must also maintain its market position against new entrants in the post-pandemic consumer spending environment.